References
- Fenaux P, Chastang C, Chevret S et al. A randomized comparison of all trans retinoic acid (ATRA) followed by chemotherapy and ATRA plus chemotherapy and the role of maintenance therapy in newly diagnosed acute promyelocytic leukemia. The European APL Group. Blood 1999; 14: 1192–1200.
- Sanz MA, Martin G, Gonzalez M et al. Risk adapted treatment ofacute promyelocytic leukemia with all Trans retinoic acid and anthracycline monochemotherapy: a multicenter study by the PETHEMA group. Blood 2004; 103 (9): 1237–1243.
- Sanz MA, Martin G, Rayon C et al. A modified AIDA protocolwith anthracyclin based consolidation result in high anti leukemia efficacy and reduced toxicity in newly diagnosed PML/RARalpha positive acute promyelocytic leukemia PETHEMA group. Blood 1999; 94: 3015–3021.
- Tallman MS, Andersen JW, Schiffer CA et al. Clinical descriptionof 44 patients with acute promyelocytic leukemia who developed the retinoic acid syndrome. Blood 2000; 95: 90–95.
- De Botton S, Dombret H, Sanz M et al. Incidence, clinical features,and outcome of all trans-retinoic acid syndrome in 413 cases of newly diagnosed acute promyelocytic leukemia. Blood 1998; 92: 2712–2727.
- Simzar S, Rotunda AM, Craft N. Scrotal ulceration as a consequence of all-trans-retinoic acid (ATRA) for the treatment of acute promyelocytic leukemia. J Drugs Demiatol, 2005; 4: 231–232.
- Frankel SR, Eardley A, Heller G et al. All-trans retinoic acid foracute promyelocyic leukemia. Results of the New York study. Ann Intern Med, 1994; 120: 278–286.
- Vahdat L, Maslak P, Miller Jr WH et al. Early mortality and the retinoic acid syndrome in acute promyelocytic leukemia: impact of leukocytosis, low-dose chemotherapy, PML/RAR-alpha isoform, and CD13 expression in patients treated with all-trans retinoic acid. Blood 1994; 84: 3843–3849.
- Von den Driesch P. Sweet's syndrome (acute febrile neutrophilic dermatosis). J Am Acad Dermatol, 1994; 45: 861–865.
- Friedman DI. Idiopathic intracranial hypertension. Curr Pain Headache Rep 2007; 11(1): 62–68.
- Cheson BD, Cassileth PA, Head DR et al. Report of the National Cancer Institute-sponsored workshop on definitions of diagnosis and response in acute myeloid leukemia. J Clin Oncol 1990; 8: 813–819.
- Dan Dower. The epidemiology of acute promyelocytic leukaemia. Best Pract Res Clin Haematol 2003; 16: 357–367.
- Cartwright RA. Leukemia. In: Whittaker JA (ed). Epidemiology. 2nd ed. Oxford: Blackwell Scientific Publications; 1995,3–33.
- Avvisati G, Mele A, Stasi MA et al. Epidemiology of acute promyelocytc leukemia in Italy. APL Collaborating Group. Ann Oncol 1991; 2: 405–408.
- Mele A, Stasi MA, Pulsoni A et al. Epidemiology of acute promyelocytic leukemia. Haematologica 1995; 80: 405–408.
- Grimwade D, Walker H, Oliver F et al. The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial. Blood 1998; 92: 2322–2333.
- Estey E, Thall P, Kantarjian H, Pierce S, Kornblau S, Keating M. Association between increased body mass index and a diagnosis of acute promyelocytic leukemia in patients with acute myeloid leukemia. Leukemia 1997; 11: 1661–1664.
- Melnick A, Licht JD. Deconstructing a disease: RAR alpha, its fusion partners and their roles in the pathogenesis of acute promyelocytic leukaemia. Blood 1998; 93: 3167–3215.
- Pedersen-Bjergaard J, Rowley JD. The balanced and the unba-lanced chromosome aberrations of acute myeloid leukemia may develop in different ways and may contribute differently to malignant transformation. Blood 1994; 83: 2780–2786.
- Schaffler A, Muller-Ladner U, Scholmerich J, Buehler C. Role of adipose tissue as an inflammatory organ in human diseases. Endocrine Rev 2006; 27: 449–467.
- konopleva M, Mikhail A, Estov Z et al. Expression and function ofleptin receptor isoforms in myeloid leukemia and myelodysplastic syndromes: proliferative and anti-apoptic activities. Blood 1999; 93: 1668–1676.
- Tabe Y, Konopleva M, Munsell MF et al. PML-RAR-a is associated with leptin-receptor induction: the role of mesenchymal stem cell-derived adipocytes in APL cell survival. Blood 2004; 103: 1815–1822.
- Cohen PR. Sweet's syndrome-a comprehensive review of an acute febrile neutrophilic dermatosis. Orphanet J Rare Dis 2007; 2: 34.
- Lampl Y, Eshel Y, Kessler A et al. Serum leptin level in women with idiopathic intracranial hypertension. Neurol Neuros Psych 2002; 72: 642–643.
- Thompson DF, Montarella KE. Drug-induced Sweet's syndrome. Ann Pharmacotherapy 2007; 41: 802–811.
- Pollack A. Handbook of essential drugs and regimens in hematolo-gical oncology. New York: Harwood Academic Publishers; 1991, 33–34.